Einloggen

Thematische Bibliographien / Genetic screening / Zeitschriftenartikel

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Genetic screening.

Zeitschriftenartikel zum Thema „Genetic screening“

Autor: Grafiati

Veröffentlicht am 4. Juni 2021

Zuletzt aktualisiert am 25. Juli 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Genetic screening" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Elias, Sherman, and George J. Annas. "Generic Consent for Genetic Screening." New England Journal of Medicine 330, no. 22 (1994): 1611–13. http://dx.doi.org/10.1056/nejm199406023302213.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Hasanova, Aytakin, and Lamiya Guliyeva. "GENETIC SCREENING." Likarska sprava, no. 1-2 (May 25, 2021): 40–44. http://dx.doi.org/10.31640/jvd.1-2.2021(6).

Der volle Inhalt der Quelle

Annotation:

Human, as a species, is very variable, and his variability is at the basis of his social organization. This variability is maintained, in part, by the chance effects of gene assortment and the variation in these genes is the result of mutations in the past. If our remote ancestors had not mutated we would not he here; further, since no species is likely to he able to reduce its mutation rate substantially by the sort of selection to which it is exposed, we may regard mutations of recent origin as part of the price of having evolved. We are here: all of us have some imperfections we would wish

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Burke, W., B. Tarini, N. A. Press, and J. P. Evans. "Genetic Screening." Epidemiologic Reviews 33, no. 1 (2011): 148–64. http://dx.doi.org/10.1093/epirev/mxr008.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Clarke, Angus. "Genetic screening." Practice Nursing 7, no. 14 (1996): 32–34. http://dx.doi.org/10.12968/pnur.1996.7.14.9823.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Williams, Janet K. "Genetic Screening." Journal of Obstetric, Gynecologic & Neonatal Nursing 14, no. 5 (1985): 350. http://dx.doi.org/10.1111/j.1552-6909.1985.tb02081.x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

McCarrick, Pat Milmoe. "Genetic Testing and Genetic Screening." Kennedy Institute of Ethics Journal 3, no. 3 (1993): 333–54. http://dx.doi.org/10.1353/ken.0.0251.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Sermon, Karen. "Preimplantation Genetic Screening." OBM Genetics 1, no. 4 (2017): 1. http://dx.doi.org/10.21926/obm.genet.1704008.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Sermon, Karen. "Preimplantation Genetic Screening." OBM Genetics 1, no. 1 (2017): 1. http://dx.doi.org/10.21926/obm.genet.1704009.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Mastenbroek, S., M. Twisk, F. van der Veen, and S. Repping. "Preimplantation genetic screening." Reproductive BioMedicine Online 17, no. 2 (2008): 293. http://dx.doi.org/10.1016/s1472-6483(10)60209-x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Harper, Joyce C. "Preimplantation genetic screening." Journal of Medical Screening 25, no. 1 (2017): 1–5. http://dx.doi.org/10.1177/0969141317691797.

Der volle Inhalt der Quelle

Annotation:

Preimplantation genetic diagnosis was first successfully performed in 1989 as an alternative to prenatal diagnosis for couples at risk of transmitting a genetic or chromosomal abnormality, such as cystic fibrosis, to their child. From embryos generated in vitro, biopsied cells are genetically tested. From the mid-1990s, this technology has been employed as an embryo selection tool for patients undergoing in vitro fertilisation, screening as many chromosomes as possible, in the hope that selecting chromosomally normal embryos will lead to higher implantation and decreased miscarriage rates. Thi

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Lalwani, Sasmira, Jeannine Witmyer, Nancy Gaba, and David Frankfurter. "Preimplantation Genetic Screening." Postgraduate Obstetrics & Gynecology 35, no. 17 (2015): 1–5. http://dx.doi.org/10.1097/01.pgo.0000471712.79930.33.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Burgin, Karen B. "Prenatal Genetic Screening." Journal of Midwifery & Women's Health 53, no. 4 (2008): 391–92. http://dx.doi.org/10.1016/j.jmwh.2008.02.002.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

Kenner, Carole, and Stephanie Amlung. "Newborn Genetic Screening: Blessing or Curse?" Neonatal Network 18, no. 7 (1999): 11–19. http://dx.doi.org/10.1891/0730-0832.18.7.11.

Der volle Inhalt der Quelle

Annotation:

Newly discovered genes and advances in genetic screening programs prompt many questions reflecting the kinds of ethical dilemmas that go hand in hand with life-changing discoveries. Neonatal genetic screening has been a standard of care for some time, but as our knowledge in the field of genetics expands, should we continue with the same approach? What newborn genetic screening tests should be mandatory, and what are the long-range consequences associated with testing? This article reviews genetic modes of inheritance, outlines and explains the most common newborn screening tests, and enumerat

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Moore, Aideen M., and Julie Richer. "Genetic testing and screening in children." Paediatrics & Child Health 27, no. 4 (2022): 243–47. http://dx.doi.org/10.1093/pch/pxac028.

Der volle Inhalt der Quelle

Annotation:

Abstract Genetic testing has progressed rapidly over the past two decades and is becoming common in paediatrics. This statement provides an overview of recent developments that may impact genetic testing in children. Genetics is a rapidly evolving field, and this statement focuses specifically on expanded newborn screening, next generation sequencing (NGS), incidental findings, direct-to-consumer testing, histocompatibility testing, and genetic testing in a research context.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Lorey, Fred. "Human Genetics Data Applied to Genetic Screening Programs." Practicing Anthropology 20, no. 2 (1998): 30–33. http://dx.doi.org/10.17730/praa.20.2.n84728r821185380.

Der volle Inhalt der Quelle

Annotation:

The uses of human genetic data in genetic screening are multifaceted and dynamic, creating an ongoing stream of useful prevalence data, ethnicity data, and natural history information. Since the primary facility for generation of these data is a large public health genetic screening program, however, the results must be continually analyzed and evaluated in the context of testing parameters. For example, presumptive positive rates (initial screening test positives, only a portion of which will become diagnosed cases), false positive rates, detection rates, and analytical values must be constan

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Ross, Lainie Friedman. "Predictive Genetic Testing of Children and the Role of the Best Interest Standard." Journal of Law, Medicine & Ethics 41, no. 4 (2013): 899–906. http://dx.doi.org/10.1111/jlme.12099.

Der volle Inhalt der Quelle

Annotation:

The genetic testing and screening of children has been fraught with controversy since Robert Guthrie developed the bacterial inhibition assay to test for phenylketonuria and advocated for rapid uptake of universal newborn screening in the early 1960s. Today with fast and affordable mass screening of the whole genome on the horizon, the debate about when and in what scenarios children should undergo genetic testing and screening has gained renewed attention. United States (US) professional guidelines — both the American College of Medical Genetics (ACMG)/American Society of Human Genetics (ASHG

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Mackey, David Anthony, Deus Bigirimana, and Sandra Elfride Staffieri. "Integrating Genetics in Glaucoma Screening." Journal of Glaucoma 33, Suppl 1 (2024): S49—S53. http://dx.doi.org/10.1097/ijg.0000000000002425.

Der volle Inhalt der Quelle

Annotation:

Précis: As additional glaucoma genes are identified and classified, polygenic risk scores will be refined, facilitating early diagnosis and treatment. Ensuring genetic research is equitable to prevent glaucoma blindness worldwide is crucial. Purpose: To review the progress in glaucoma genetics over the past 25 years, including the identification of genes with varying contributions to the disease and the development of polygenic risk scores. Methods/Results: Over the last 2 and a half decades, glaucoma genetics has evolved from identifying genes with Mendelian inheritance patterns, such as myoc

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Victor Maafo, E. "Research Note: Genetic Engineering and Genetic Screening." Competitiveness Review 11, no. 1 (2001): 83–84. http://dx.doi.org/10.1108/eb046421.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Sullivan-Pyke, Chantae, and Anuja Dokras. "Preimplantation Genetic Screening and Preimplantation Genetic Diagnosis." Obstetrics and Gynecology Clinics of North America 45, no. 1 (2018): 113–25. http://dx.doi.org/10.1016/j.ogc.2017.10.009.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Nolan, Kathleen. "First Fruits: Genetic Screening." Hastings Center Report 22, no. 4 (1992): S2. http://dx.doi.org/10.2307/3563030.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Holden, Constance. "Employers Shun Genetic Screening." Science 250, no. 4982 (1990): 752. http://dx.doi.org/10.1126/science.250.4982.752.b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Traeger-Synodinos, Johanne, and François Rousseau. "Introduction to Genetic Screening." OBM Genetics 3, no. 3 (2019): 1. http://dx.doi.org/10.21926/obm.genet.1903094.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Javaher, P., E. Nyoungui, H. Kääriäinen, et al. "Genetic Screening in Europe." Public Health Genomics 13, no. 7-8 (2010): 524–37. http://dx.doi.org/10.1159/000294998.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Carlsson, Christina, Mats Jonsson, Bengt Nordén, et al. "Screening for genetic mutations." Nature 380, no. 6571 (1996): 207. http://dx.doi.org/10.1038/380207a0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Mills, Catherine. "GENETIC SCREENING AND SELFHOOD." Australian Feminist Studies 23, no. 55 (2008): 43–55. http://dx.doi.org/10.1080/08164640701816207.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Grody, Wayne W. "Molecular Genetic Risk Screening." Annual Review of Medicine 54, no. 1 (2003): 473–90. http://dx.doi.org/10.1146/annurev.med.54.101601.152127.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Lea, Dale Halsey, and Janet K. Williams. "Genetic Testing and Screening." AJN, American Journal of Nursing 102, no. 7 (2002): 36–43. http://dx.doi.org/10.1097/00000446-200207000-00035.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Motulsky, Arno G. "Screening for Genetic Diseases." New England Journal of Medicine 336, no. 18 (1997): 1314–16. http://dx.doi.org/10.1056/nejm199705013361810.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Caskey, C. Thomas, Manuel L. Gonzalez-Garay, Stacey Pereira, and Amy L. McGuire. "Adult Genetic Risk Screening." Annual Review of Medicine 65, no. 1 (2014): 1–17. http://dx.doi.org/10.1146/annurev-med-111212-144716.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Smith, Richard J. H., and Stephen Hone. "Genetic screening for deafness." Pediatric Clinics of North America 50, no. 2 (2003): 315–29. http://dx.doi.org/10.1016/s0031-3955(03)00026-9.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Williams, D. K., and I. D. Young. "Implications of genetic screening." Current Obstetrics & Gynaecology 7, no. 3 (1997): 180–81. http://dx.doi.org/10.1016/s0957-5847(97)80082-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Harper, Peter S. "What is Genetic Screening?" Journal of Medical Screening 3, no. 3 (1996): 165–66. http://dx.doi.org/10.1177/096914139600300314.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Gregg, Anthony R., and Joe Leigh Simpson. "Genetic screening and counseling." Obstetrics and Gynecology Clinics of North America 29, no. 2 (2002): xi—xii. http://dx.doi.org/10.1016/s0889-8545(02)00006-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Washburn, Newell R. "Screening for genetic anomalies." American Journal of Obstetrics and Gynecology 157, no. 1 (1987): 212. http://dx.doi.org/10.1016/s0002-9378(87)80384-8.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Connor, J. Michael. "Screening for genetic abnormality." Fetal and Maternal Medicine Review 1, no. 01 (1989): 13. http://dx.doi.org/10.1017/s096553950000005x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Philip, Nicole. "Screening for genetic disorders." Child's Nervous System 19, no. 7-8 (2003): 436–39. http://dx.doi.org/10.1007/s00381-003-0779-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Williams, Janet K. "Screening for genetic disorders." Journal of Pediatric Health Care 3, no. 3 (1989): 115–21. http://dx.doi.org/10.1016/0891-5245(89)90060-6.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Uzych, L. "Genetic screening and ethics." Journal of Medical Ethics 22, no. 1 (1996): 53–54. http://dx.doi.org/10.1136/jme.22.1.53.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Crisp, R. "Genetic screening: ethical issues." Journal of Medical Ethics 20, no. 4 (1994): 264–65. http://dx.doi.org/10.1136/jme.20.4.264.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

KOLATA, G. "Genetic Screening Issues Studied." Science 232, no. 4748 (1986): 318. http://dx.doi.org/10.1126/science.232.4748.318.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Norton, Mary E. "Genetic screening and counseling." Current Opinion in Obstetrics and Gynecology 20, no. 2 (2008): 157–63. http://dx.doi.org/10.1097/gco.0b013e3282f73230.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Elias, Sherman, and George J. Annas. "Routine Prenatal Genetic Screening." New England Journal of Medicine 317, no. 22 (1987): 1407–9. http://dx.doi.org/10.1056/nejm198711263172208.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Lau, Tze Kin, and Tse Ngong Leung. "Genetic screening and diagnosis." Current Opinion in Obstetrics and Gynecology 17, no. 2 (2005): 163–69. http://dx.doi.org/10.1097/01.gco.0000162187.99219.e0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Cao, Antonio, Maria Cristina Rosatelli, and Renzo Galanello. "Population-based genetic screening." Current Opinion in Genetics & Development 1, no. 1 (1991): 48–53. http://dx.doi.org/10.1016/0959-437x(91)80040-s.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Orentlicher, David. "Genetic Screening by Employers." JAMA: The Journal of the American Medical Association 263, no. 7 (1990): 1005. http://dx.doi.org/10.1001/jama.1990.03440070093040.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Cornel, Martina C., Karuna R. M. van der Meij, Carla G. van El, Tessel Rigter, and Lidewij Henneman. "Genetic Screening—Emerging Issues." Genes 15, no. 5 (2024): 581. http://dx.doi.org/10.3390/genes15050581.

Der volle Inhalt der Quelle

Annotation:

In many countries, some form of genetic screening is offered to all or part of the population, either in the form of well-organized screening programs or in a less formalized way. Screening can be offered at different phases of life, such as preconception, prenatal, neonatal and later in life. Screening should only be offered if the advantages outweigh the disadvantages. Technical innovations in testing and treatment are driving changes in the field of prenatal and neonatal screening, where many jurisdictions have organized population-based screening programs. As a result, a greater number and

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Motulsky, Arno G. "Societal problems in human and medical genetics." Genome 31, no. 2 (1989): 870–75. http://dx.doi.org/10.1139/g89-153.

Der volle Inhalt der Quelle

Annotation:

The applications of human and medical genetics raise many societal and ethical problems. This paper deals with a variety of such issues posed by current and future developments in genetic counseling, genetic screening, prenatal and predictive diagnosis, and gene therapy. The promise and problems of behavioral genetics are discussed. Problems of privacy, decision making, societal pressures, stigmatization, and informed consent to genetic study are raised. Use of genetic data by insurance companies or other public groups is discussed. The rapid unfolding of genetic information affecting human he

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Markossian, Sarine, Kenny K. Ang, Christopher G. Wilson, and Michelle R. Arkin. "Small-Molecule Screening for Genetic Diseases." Annual Review of Genomics and Human Genetics 19, no. 1 (2018): 263–88. http://dx.doi.org/10.1146/annurev-genom-083117-021452.

Der volle Inhalt der Quelle

Annotation:

The genetic determinants of many diseases, including monogenic diseases and cancers, have been identified; nevertheless, targeted therapy remains elusive for most. High-throughput screening (HTS) of small molecules, including high-content analysis (HCA), has been an important technology for the discovery of molecular tools and new therapeutics. HTS can be based on modulation of a known disease target (called reverse chemical genetics) or modulation of a disease-associated mechanism or phenotype (forward chemical genetics). Prominent target-based successes include modulators of transthyretin, u

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Brezina, Paul R., Raymond W. Ke, and William H. Kutteh. "Preimplantation Genetic Screening: A Practical Guide." Clinical Medicine Insights: Reproductive Health 7 (January 2013): CMRH.S10852. http://dx.doi.org/10.4137/cmrh.s10852.

Der volle Inhalt der Quelle

Annotation:

The past several decades have seen tremendous advances in the field of medical genetics. The application of genetic technologies to the field of reproductive medicine has ushered in a new era of medicine that is likely to greatly expand in the coming years. Concurrent with an in vitro fertilization (IVF) cycle, it is now possible to obtain a cellular biopsy from a developing embryo and genetically evaluate this sample with increasing sophistication and detail. Preimplantation genetic screening (PGS) is the practice of determining the presence of aneuploidy (either too many or too few chromosom

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

van El, Carla Geertruida, Toine Pieters, and Martina Cornel. "Genetic screening and democracy: lessons from debating genetic screening criteria in the Netherlands." Journal of Community Genetics 3, no. 2 (2011): 79–89. http://dx.doi.org/10.1007/s12687-011-0063-z.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!